Recombinant tissue plasminogen activator treatment for intracardiac vegetation in a very low birth weight infant

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Cardiology

Background:

• Neonatal intensive care unit (NICU) survival has improved, but this is associated with increased risks of nosocomial infections, including invasive fungal infections.
• Invasive fungal infections (IFIs) in neonates carry high morbidity and mortality, with potential for end-organ dissemination.

Observation:

• A rare case of intracardiac vegetation, a life-threatening complication of IFIs, was observed in a low birth weight premature infant.
• The infant presented with a fungal endocarditis, a condition typically requiring aggressive antifungal therapy and potentially surgical intervention.

Findings:

• The infant was successfully treated with caspofungin, a systemic antifungal agent, and recombinant tissue plasminogen activator.
• This non-surgical approach effectively managed the intracardiac vegetation and fungal infection.

Implications:

• This case demonstrates a viable alternative to surgery for fungal endocarditis in neonates.
• The findings suggest that a combination of caspofungin and thrombolytic therapy may be a promising treatment strategy for invasive fungal endocarditis in high-risk infant populations.